Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
IPO
Biotech
BioXcel’s oncology spinout OnkosXcel sets out for ‘surprise’ IPO
In a move that analysts called surprising, BioXcel Therapeutics is moving immuno-oncology subsidiary OnkosXcel towards an IPO.
Gabrielle Masson
Mar 15, 2023 11:51am
Mineralys upsizes IPO to raise $192M for race with AstraZeneca
Feb 10, 2023 9:10am
Structure finalizes $111M IPO; Intensity plots offering
Jan 30, 2023 10:59am
UK biotech IPOs fell to lowest level for a decade: report
Jan 27, 2023 9:05am
Mineralys polishes $100M IPO ahead of phase 3 hypertension trial
Jan 19, 2023 9:10am
Gene editing biotech Prime turns up the heat with $175M IPO
Oct 20, 2022 12:05pm
